Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.

Kaito S, Sekiya N, Najima Y, Suzuki T, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Inamoto K, Yoshifuji K, Akiyama M, Toya T, Igarashi A, Muto H, Doki N, Kobayashi T, Kakihana K, Ohashi K.

Bone Marrow Transplant. 2019 May 29. doi: 10.1038/s41409-019-0541-1. [Epub ahead of print] No abstract available.

PMID:
31142797
2.

[Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation].

Adachi H, Doki N, Hino Y, Senoo Y, Ikegawa S, Watanabe D, Inamoto K, Yoshioka K, Najima Y, Kobayashi T, Kakihana K, Haraguchi K, Kitahara Y, Okuyama Y, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2019;60(4):296-301. doi: 10.11406/rinketsu.60.296. Japanese.

PMID:
31068559
3.

The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome".

Kaito S, Sekiya N, Najima Y, Sano N, Horiguchi S, Kakihana K, Hishima T, Ohashi K.

Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2793-19. [Epub ahead of print] No abstract available.

4.

Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.

Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13.

PMID:
30989487
5.

Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission.

Konishi T, Doki N, Kishida Y, Nagata A, Yamada Y, Kaito S, Kurosawa S, Yoshifuji K, Shirane S, Uchida T, Inamoto K, Toya T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Ann Hematol. 2019 Jul;98(7):1799-1801. doi: 10.1007/s00277-019-03668-0. Epub 2019 Mar 21. No abstract available.

PMID:
30899981
6.

Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.

Tanaka K, Toyota S, Akiyama M, Wakimoto N, Nakamura Y, Najima Y, Doki N, Kakihana K, Igarashi A, Kobayashi T, Ohashi K, Kudo D, Shinagawa A, Takano H, Fujio T, Okoshi Y, Hori M, Kumagai T, Saito T, Mukae J, Yamamoto K, Tsutsumi I, Komeno T, Yoshida C, Yamamoto M, Kojima H; on behalf of the Ochanomizu Hematology Study Group.

Acta Haematol. 2019;141(2):111-118. doi: 10.1159/000495338. Epub 2019 Feb 6.

PMID:
30726834
7.

Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens.

Yasuda S, Najima Y, Konishi T, Yamada Y, Takezaki T, Kurosawa S, Sakaguchi M, Harada K, Yoshioka K, Igarashi A, Inamoto K, Toya T, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Sekiya N, Ohashi K.

J Infect Chemother. 2019 May;25(5):371-375. doi: 10.1016/j.jiac.2018.11.011. Epub 2019 Jan 11.

PMID:
30642772
8.

Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.

Kaito S, Toya T, Yoshifuji K, Kurosawa S, Inamoto K, Takeshita K, Suda W, Kakihana K, Honda K, Hattori M, Ohashi K.

Blood Adv. 2018 Nov 27;2(22):3097-3101. doi: 10.1182/bloodadvances.2018024968. No abstract available.

9.

Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions.

Shingai N, Kaito S, Yamada Y, Konishi T, Nagata A, Kurosawa S, Watakabe-Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Transpl Infect Dis. 2019 Feb;21(1):e13023. doi: 10.1111/tid.13023. Epub 2018 Nov 29.

PMID:
30407701
10.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Blood Adv. 2018 Oct 23;2(20):2744-2754. doi: 10.1182/bloodadvances.2018020305.

11.

Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.

Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S.

Bone Marrow Transplant. 2019 Apr;54(4):578-586. doi: 10.1038/s41409-018-0301-7. Epub 2018 Aug 14.

PMID:
30108330
12.

Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas maltophilia: A Rare and Underrecognized Entity.

Kaito S, Sekiya N, Najima Y, Sano N, Horiguchi S, Kakihana K, Hishima T, Ohashi K.

Intern Med. 2018 Dec 15;57(24):3667-3671. doi: 10.2169/internalmedicine.1227-18. Epub 2018 Aug 10.

13.

Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation.

Kurosawa S, Toya T, Kishida Y, Nagata A, Yamada Y, Konishi T, Kaito S, Yoshifuji K, Matsuyama N, Shirane S, Uchida T, Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Leuk Lymphoma. 2018 Dec;59(12):3006-3009. doi: 10.1080/10428194.2018.1441410. Epub 2018 Apr 4. No abstract available.

PMID:
29616841
14.

[Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].

Kurosawa S, Sekiya N, Muraosa Y, Kamei K, Nagata A, Yamada Y, Konishi T, Takezaki T, Kaito S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Inamoto K, Toya T, Igarashi A, Najima Y, Muto H, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2017;58(12):2375-2379. doi: 10.11406/rinketsu.58.2375. Japanese.

PMID:
29332869
15.

Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.

Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihana K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y.

Bone Marrow Transplant. 2018 Apr;53(4):478-482. doi: 10.1038/s41409-017-0028-x. Epub 2018 Jan 12. No abstract available.

PMID:
29330394
16.

Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation.

Ikeuchi K, Doki N, Takao A, Hishima T, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Muto H, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Intern Med. 2017 Dec 1;56(23):3215-3217. doi: 10.2169/internalmedicine.8646-16. Epub 2017 Sep 25.

17.

Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.

Harada K, Sekiya N, Konishi T, Nagata A, Yamada Y, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Sasaki S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

BMC Infect Dis. 2017 Sep 22;17(1):638. doi: 10.1186/s12879-017-2745-6.

18.

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG.

Sakura T, Hayakawa F, Sugiura I, Murayama T, Imai K, Usui N, Fujisawa S, Yamauchi T, Yujiri T, Kakihana K, Ito Y, Kanamori H, Ueda Y, Miyata Y, Kurokawa M, Asou N, Ohnishi K, Ohtake S, Kobayashi Y, Matsuo K, Kiyoi H, Miyazaki Y, Naoe T.

Leukemia. 2018 Mar;32(3):626-632. doi: 10.1038/leu.2017.283. Epub 2017 Sep 15.

PMID:
28914260
19.

Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.

Doki N, Suyama M, Sasajima S, Ota J, Igarashi A, Mimura I, Morita H, Fujioka Y, Sugiyama D, Nishikawa H, Shimazu Y, Suda W, Takeshita K, Atarashi K, Hattori M, Sato E, Watakabe-Inamoto K, Yoshioka K, Najima Y, Kobayashi T, Kakihana K, Takahashi N, Sakamaki H, Honda K, Ohashi K.

Ann Hematol. 2017 Sep;96(9):1517-1523. doi: 10.1007/s00277-017-3069-8. Epub 2017 Jul 21.

PMID:
28733895
20.

Fecal microbiota transplantation for acute graft-versus-host disease of the gut.

Kakihana K.

Rinsho Ketsueki. 2017;58(5):499-505. doi: 10.11406/rinketsu.58.499. Japanese.

PMID:
28592766
21.

Gut microbiota and acute graft-versus-host disease.

Yoshioka K, Kakihana K, Doki N, Ohashi K.

Pharmacol Res. 2017 Aug;122:90-95. doi: 10.1016/j.phrs.2017.05.028. Epub 2017 May 30. Review.

PMID:
28576475
22.

Erythrocytosis after allogeneic hematopoietic stem cell transplantation.

Hino Y, Doki N, Kurosawa S, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Hattori K, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12918. Epub 2017 Feb 28. No abstract available.

PMID:
28247439
23.

Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Fujisawa S, Mizuta S, Akiyama H, Ueda Y, Aoyama Y, Hatta Y, Kakihana K, Dobashi N, Sugiura I, Onishi Y, Maeda T, Imai K, Ohtake S, Miyazaki Y, Ohnishi K, Matsuo K, Naoe T.

Am J Hematol. 2017 Apr;92(4):367-374. doi: 10.1002/ajh.24653. Epub 2017 Feb 21.

24.

Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment for Toxoplasma.

Senoo Y, Sekiya N, Sasaki S, Yoshioka K, Watakabe-Inamoto K, Hagino T, Muto H, Najima Y, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12666. Epub 2017 Mar 16. No abstract available.

PMID:
28100042
25.

Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience.

Senoo Y, Yoshioka K, Kaito S, Kurosawa S, Harada K, Yamamoto K, Hino Y, Sakaguchi M, Ikegawa S, Watanabe D, Watakabe K, Hagino T, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2016;57(12):2481-2489. doi: 10.11406/rinketsu.57.2481. Japanese.

PMID:
28090014
26.

Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.

Ikegawa S, Doki N, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Pathol Oncol Res. 2017 Apr;23(2):433-437. doi: 10.1007/s12253-016-0162-6. Epub 2016 Dec 21.

PMID:
28004352
27.

Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.

Yamamoto K, Doki N, Senoo Y, Najima Y, Kobayashi T, Kakihana K, Haraguchi K, Okuyama Y, Sakamaki H, Ohashi K.

Transfus Med Hemother. 2016 Nov;43(6):433-435. Epub 2016 Oct 18.

28.

Donor cell leukemia with bone marrow necrosis.

Ikegawa S, Najima Y, Sano N, Horiguchi SI, Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Senoo Y, Watanabe D, Yoshioka K, Watakabe K, Igarashi A, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Hishima T, Ohashi K.

Rinsho Ketsueki. 2016;57(11):2334-2338. Japanese.

PMID:
27941282
29.

Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Hattori K, Doki N, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Harada K, Ikegawa S, Shingai N, Senoo Y, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Ann Hematol. 2017 Feb;96(2):319-321. doi: 10.1007/s00277-016-2854-0. Epub 2016 Oct 21. No abstract available.

PMID:
27766393
30.

Central nervous system infection following allogeneic hematopoietic stem cell transplantation.

Hanajiri R, Kobayashi T, Yoshioka K, Watanabe D, Watakabe K, Murata Y, Hagino T, Seno Y, Najima Y, Igarashi A, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):22-28. doi: 10.1016/j.hemonc.2016.08.008. Epub 2016 Sep 17.

31.

Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.

Harada K, Yamada Y, Konishi T, Nagata A, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.

Int J Hematol. 2016 Dec;104(6):709-719. Epub 2016 Aug 26.

PMID:
27565504
32.

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.

Kakihana K, Fujioka Y, Suda W, Najima Y, Kuwata G, Sasajima S, Mimura I, Morita H, Sugiyama D, Nishikawa H, Hattori M, Hino Y, Ikegawa S, Yamamoto K, Toya T, Doki N, Koizumi K, Honda K, Ohashi K.

Blood. 2016 Oct 20;128(16):2083-2088. doi: 10.1182/blood-2016-05-717652. Epub 2016 Jul 26.

33.

A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation.

Yamamoto M, Ohashi K, Kakihana K, Nakamura Y, Komeno T, Kojima H, Morita S, Sakamaki H.

Mol Clin Oncol. 2016 Jun;4(6):965-970. Epub 2016 Mar 28.

34.

Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation.

Hino Y, Doki N, Yamamoto K, Senoo Y, Sasajima S, Sakaguchi M, Hattori K, Kaito S, Kurosawa S, Harada K, Ikegawa S, Watanabe D, Hagino T, Yoshioka K, Watakabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2016 May;57(5):608-12. doi: 10.11406/rinketsu.57.608. Japanese.

PMID:
27263786
35.

Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease.

Harada K, Kurosawa S, Hino Y, Yamamoto K, Sakaguchi M, Ikegawa S, Hattori K, Igarashi A, Watakabe K, Senoo Y, Najima Y, Hagino T, Doki N, Kobayashi T, Kakihana K, Iino T, Sakamaki H, Ohashi K.

Springerplus. 2016 Apr 23;5:512. doi: 10.1186/s40064-016-2161-1. eCollection 2016.

36.

[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis].

Kurosawa S, Doki N, Kaito S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, Ikegawa S, Yosioka K, Watanabe D, Senoo Y, Watakabe K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Miyawaki S, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2016 Apr;57(4):461-6. doi: 10.11406/rinketsu.57.461. Review. Japanese.

PMID:
27169451
37.

The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Ishida S, Doki N, Shingai N, Yoshioka K, Kakihana K, Sakamaki H, Ohashi K.

Ann Hematol. 2016 Jun;95(7):1145-50. doi: 10.1007/s00277-016-2654-6. Epub 2016 Apr 15.

PMID:
27079957
38.

Steroid Pulse Therapy for Blood Cell Recovery in Allogeneic Hematopoietic Stem Cell Transplantation.

Murata Y, Kudo Y, Kakihana K, Abe K, Kobayashi T, Doki N, Sakamaki H, Ohashi K.

Intern Med. 2016;55(6):583-7. doi: 10.2169/internalmedicine.55.4174. Epub 2016 Mar 15.

39.

Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia.

Kurosawa S, Doki N, Hino Y, Sakaguchi M, Fukushima K, Shingai N, Hattori K, Watanabe K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Intern Med. 2016;55(4):395-7. doi: 10.2169/internalmedicine.55.5400. Epub 2016 Feb 15.

40.

Gastric Antral Vascular Ectasia during the Treatment of Chronic Myelogenous Leukemia with Imatinib Mesylate.

Narukawa K, Kakihana K, Fujiwara T, Kobayashi T, Doki N, Sakamaki H, Ohashi K.

Intern Med. 2016;55(1):69-72. doi: 10.2169/internalmedicine.55.4166.

41.

A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.

Kanda Y, Kobayashi T, Mori T, Tanaka M, Nakaseko C, Yokota A, Watanabe R, Kako S, Kakihana K, Kato J, Tanihara A, Doki N, Ashizawa M, Kimura SI, Kikuchi M, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy.

Bone Marrow Transplant. 2016 Jan;51(1):103-9. doi: 10.1038/bmt.2015.222. Epub 2015 Oct 5.

PMID:
26437063
42.

CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.

Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K.

Leuk Lymphoma. 2016;57(6):1375-81. doi: 10.3109/10428194.2015.1099644. Epub 2015 Dec 23.

PMID:
26422713
43.

Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation.

Doki N, Haraguchi K, Hagino T, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Okuyama Y, Sakamaki H, Ohashi K.

Ann Hematol. 2015 Dec;94(12):2055-60. doi: 10.1007/s00277-015-2492-y. Epub 2015 Sep 4.

PMID:
26336968
44.

Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients.

Shingai N, Morito T, Najima Y, Kobayashi T, Doki N, Kakihana K, Ohashi K, Ando M.

Bone Marrow Transplant. 2015 Dec;50(12):1557-62. doi: 10.1038/bmt.2015.188. Epub 2015 Aug 24.

PMID:
26301965
45.

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.

Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T; Japan Study Group for Cell Therapy and Transplantation.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1646-52. doi: 10.1016/j.bbmt.2015.06.008. Epub 2015 Jun 18.

46.

Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.

Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Watanabe K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Leuk Lymphoma. 2016;57(1):76-80. doi: 10.3109/10428194.2015.1063148.

PMID:
26084204
47.

Incidental detection of congenital Robertsonian translocation at diagnosis of Philadelphia chromosome-positive acute lymphocytic leukemia.

Yamaguchi T, Igarashi A, Kawamura M, Ozasa Y, Yoshida M, Kakihana K, Sakamaki H, Ohashi K.

Rinsho Ketsueki. 2015 May;56(5):481-4. doi: 10.11406/rinketsu.56.481. Japanese.

PMID:
26062669
48.

Tobacco smoking is associated with infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.

Hanajiri R, Kakihana K, Kobayashi T, Doki N, Sakamaki H, Ohashi K.

Bone Marrow Transplant. 2015 Aug;50(8):1141-3. doi: 10.1038/bmt.2015.116. Epub 2015 May 18. No abstract available.

PMID:
25985052
49.

Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome.

Oshikawa G, Yoshioka K, Takahashi Y, Shingai N, Ikegawa S, Kobayashil T, Doki N, Kakihana K, Ohashi K, Sakamaki H.

Pathol Oncol Res. 2015 Sep;21(4):1037-43. doi: 10.1007/s12253-015-9933-8. Epub 2015 Apr 3.

PMID:
25837848
50.

Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia.

Oshikawa G, Kakihana K, Saito M, Aoki J, Najima Y, Kobayashi T, Doki N, Sakamaki H, Ohashi K.

Br J Haematol. 2015 Jun;169(5):756-9. doi: 10.1111/bjh.13248. Epub 2014 Dec 17. No abstract available.

PMID:
25522128

Supplemental Content

Loading ...
Support Center